The effects of continuous antidepressant treatment during the first 6 months on relapse or recurrence of depression

Journal of Affective Disorders

Volumn 132, Issue 1-2, 2011, Pages 121-129

  Kim, Kyoung Hoon ^a   Lee, Seung Mi ^a   Paik, Jong Woo ^b   Kim, Nam Soon ^c,d  

^a Health Insurance Review Agency   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

^c Korea institute for Health and Social Affairs   (South Korea)

^d Korea Inst Hlth and Social Aff   (South Korea)

Author keywords

Antidepressant treatment; Depression; Recurrence; Relapse

Indexed keywords

AMFEBUTAMONE; AMINEPTINE; AMITRIPTYLINE; AMOXAPINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DEOXYACTEIN; DOSULEPIN; DOXEPIN; FLUOXETINE; FLUVOXAMINE; HYPERICIN; IMIPRAMINE; MIANSERIN; MILNACIPRAN; MIRTAZAPINE; MOCLOBEMIDE; NEFAZODONE; NORTRIPTYLINE; PAROXETINE; QUINUPRAMINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TIANEPTINE; TOLOXATONE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; VENLAFAXINE;

ADULT; AGED; ALCOHOLISM; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; DRUG WITHDRAWAL; DYSTHYMIA; ELECTROCONVULSIVE THERAPY; EMERGENCY WARD; EVIDENCE BASED MEDICINE; FEMALE; FOLLOW UP; HAZARD RATIO; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIXED ANXIETY AND DEPRESSION; NATIONAL HEALTH INSURANCE; PRESCRIPTION; PRIORITY JOURNAL; PSYCHIATRIC TREATMENT; RECURRENT DISEASE; RELAPSE; RISK FACTOR; RISK REDUCTION; SOUTH KOREA; SUICIDE ATTEMPT; TREATMENT DURATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; ANXIETY DISORDERS; COHORT STUDIES; COMORBIDITY; DEPRESSIVE DISORDER; DYSTHYMIC DISORDER; FEMALE; HEALTH SERVICES RESEARCH; HUMANS; LONG-TERM CARE; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; ODDS RATIO; RECURRENCE; REPUBLIC OF KOREA; RETREATMENT; RETROSPECTIVE STUDIES; SEX FACTORS; YOUNG ADULT;

EID: 79958178780     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2011.02.016     Document Type: Article

References (35)

1. A. Akincigil, J.R. Bowblis, C. Levin, J.T. Walkup, S. Jan, and S. Crystal Adherence to antidepressants treatment among privately insured patients diagnosed with depression Med. Care 45 2007 363 369
2. American Psychiatric Association Practice Guideline for the Treatment of Patients with Major Depressive Disorder 2000 American Psychiatric Association Washington DC
3. I.M. Anderson Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability J. Affect. Disord. 58 2000 19 36 (Pubitemid 30173208)
4. M.B.J. Blom, P. Spinhoven, T. Hoffman, K. Jonker, E. Hoencamp, P.M.J. Haffmans, and R. van Dyck Severity and duration of depression, not personality factors, predict short term outcome in the treatment of major depression J. Affect. Disord. 104 2007 119 126 (Pubitemid 350052321)
5. A. Charbonneau, A.K. Rosen, R.R. Owen, A. Spiro, A.S. Ash, D.R. Miller, L. Kazis, B. Kader, F. Cunningham, and D.R. Berlowitz Monitoring depression care in search of an accurate quality indicator Med. Care 42 2004 522 531
6. A.J. Claxton, Z. Li, and J. Mckendrick Selective serotonin reuptake inhibitor treatment in the UK: risk of relapse or recurrence of depression Br. J. Psychiatry 177 2000 163 168 (Pubitemid 30624829)
7. J. Davidson, and D. Raft Use of phenelzine in continuation therapy Neuropsychobiology 11 1984 191 194 (Pubitemid 14093424)
8. R.L. Dunn, J.M. Donoghue, R.J. Ozminkowski, D. Stephenson, and T.R. Hylan Longitudinal patterns of antidepressant prescribing in primary care in the UK: comparison with treatment guidelines J. Psychopharmacol. 13 2 1999 136 143 (Pubitemid 29276823)
9. H. Gardarsdottir, T.C. Egberts, J.J. Stolker, and E.R. Heerdink Duration of antidepressant drug treatment and its influence on risk of relapse/recurrence: immortal and neglected bias Am. J. Epidemiol. 170 2009 280 285
10. J.R. Geddes, S.M. Carney, C. Davies, T.A. Furukawa, D.J. Kupfer, E. Frank, and G.M. Goodwin Relapse prevention with antidepressant drug treatment in depressive disorder: systematic review Lancet 361 2003 653-651
11. S.B. Guze, and E. Robins Suicide and primary affective disorders Br. J. Psychiatry 117 1970 437 438
12. L.E. Jones, C. Turvey, and C. Carney-Doebbeling Inadequate follow-up care for depression and its impact on antidepressant treatment duration among veterans with and without diabetes mellitus in the Veterans Health Administration Gen. Hos. Psychiatry 28 2006 465 474 (Pubitemid 44667032)
13. G.I. Keitner, C.E. Ryan, I.W. Miller, R. Kohn, and N.B. Epstein 12-month outcome of patients with major depression and comorbid psychiatric or medical illness (compound depression) Am. J. Psychiatry 148 1991 345 350
14. R.C. Kessler, K.A. McGonagle, S. Zhao, C.B. Nelson, M. Hughes, S. Eshleman, H.U. Wittchen, and K.S. Kendler Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey Arch. Gen. Psychiatry 51 1994 8 19 (Pubitemid 24028993)
15. A.K. Koike, J. Unützer, and K.B. Wells Improving the care for depression in patients with comorbid medical illness Am. J. Psychiatry 159 2002 1738 1745
16. D.J. Kupfer Long term treatment of depression J. Clin. Psychiatry 52 1991 28 34
17. K.U. Lee, W. Kim, K.J. Min, Y.C. Shin, S.K. Chung, and W.M. Bahk The rate and risk factors of early discontinuation of antidepressant treatment in patients with major depressive disorder Korean J. Psychopharmacol. 17 2006 550 556
18. S. MacGillivray, B. Arroll, S. Hatcher, S. Ogston, I. Reid, F. Sullivan, B. Williams, and I. Crombie Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis BMJ 326 2003 1014
19. T.K. Melartin, H.J. Rytsälä, U.S. Leskelä, P.S. Lestelä-Mielonen, T.P. Sokero, and E.T. Isometsä Severity and comorbidity predict episode duration and recurrence of DSM-IV major depressive disorder J. Clin. Psychiatry 65 2004 810 819
20. C.A. Melfi, and T.W. Croghan Use of claims data for research on treatment and outcome of depression care Med. Care 37 1999 AS77 AS80
21. C.A. Melfi, A.J. Chawla, T.W. Croghan, M.P. Hanna, S. Kennedy, and K. Sredl The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression Arch. Gen. Psychiatry 55 1998 1128 1132 (Pubitemid 28558286)
22. Ministry of Health & Welfare The epidemiological survey of psychiatric Illnesses in Korea 2006 2007 Ministry of Health & Welfare Seoul
23. A.J. Mitchell, and H. Subramaniam Prognosis of depression in old age compared to middle age: a systematic review of comparative studies Am. J. Psychiatry 162 2005 1588 1601 (Pubitemid 41318227)
24. S.A. Montgomery, J.G.C. Rasmussen, and P. Tanghøj A 24-week study of 20 mg citalopram, 40 mg citalopram, and placebo in the prevention of relapse of major depression Int. Clin. Psychopharmacol. 8 3 1993 181 188 (Pubitemid 23294925)
25. P.G. Mottram, K. Wilson, and J.J. Strobl Antidepressants for depressed elderly Cochrane Database of Systematic Reviews 2006 10.1002/14651858 Issue 1, Art. No.:CD003491, CD003491.pub2
26. Organisation for Economic Co-operation and Development OECD Health Data 2008 Statistics and Indicators for 30 countries Organisation for Economic Co-operation and Development, Paris. 2008
27. B.J. Park, J.H. Sung, K.D. Park, S.W. Suh, and S.H. Kim Working paper on the plan of raising the validity of disease coding and improving the utilization of National Health Insurance Data 2003 Seoul National University College of Medicine Seoul
28. R.F. Prien, and D.J. Kupfer Continuation therapy for major depressive episodes: how long should it maintained? Am. J. Psychiatry 143 1986 18 23 (Pubitemid 16185856)
29. H. Quan, V. Sundararajan, P. Halfon, A. Fong, B. Burnand, J.C. Luthi, L.D. Saunders, C.A. Beck, T.E. Feasby, and W.A. Ghali Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data Med. Care 43 2005 1130 1139 (Pubitemid 41587600)
30. R.C. Shelton The nature of the discontinuation syndrome associated with antidepressant drugs J. Clin. Psychiatry 67 suppl 4 2006 3 7 (Pubitemid 43764531)
31. G.E. Simon, M.V. Korff, C.M. Rutter, and D.A. Peterson Treatment process and outcomes for managed care patients receiving new antidepressant prescriptions from psychiatrist sand primary care physicians Arch. Gen. Psychiatry 58 2001 395 401 (Pubitemid 32299536)
32. N. Sood, M. Treglia, R.L. Obenchain, B. Dulisse, C.A. Melfi, and T.W. Croghan Determinants of antidepressant treatment outcome Am. J. Manag. Care 6 2000 1327 1336 (Pubitemid 32043656)
33. K.B. Wells, M. Schoenbaum, J. Unützer, I.T. Lagomasino, and L.V. Rubenstein Quality of care for primary care patients with depression in managed care Arch. Fam. Med. 8 1999 529 536
34. World Health Organization The World Health Report: 2001: Mental Health: New Understanding, New Hope 2001 World Health Organization Geneva
35. A.S. Young, R. Klap, C.D. Sherbourne, and K.B. Wells The quality of care for depressive and anxiety disorders in the United States Arch. Gen. Psychiatry 58 2001 55 61 (Pubitemid 32057765)